Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Where Morphological and Molecular Classifications Meet: The Role of p53 Immunohistochemistry in the Prognosis of Low-Risk Endometrial Carcinoma (GLAMOUR Study).
Puppo A, Fraternali Orcioni G, Clignon V, Musizzano Y, Zavattero CA, Vocino Trucco G, Benazzo GM, Vizzielli G, Restaino S, Mariuzzi L, Orsaria M, Seracchioli R, Raimondo D, Bertoldo L, Uccella S, Caliò A, Vittori Antisari G, Garzon S, Capozzi VA, Berretta R, Cosentino F, Ercoli A, Ieni A, Arcieri M, Ceccaroni M, Pesci A, Mantovani G, Bruni F, Roviglione G, Zeppa P, Raffone A, Camanni M, Delpiano EM, Provenza C, Borghese M, Migliaretti G. Puppo A, et al. Among authors: migliaretti g. Cancers (Basel). 2024 Mar 7;16(6):1088. doi: 10.3390/cancers16061088. Cancers (Basel). 2024. PMID: 38539423 Free PMC article.
SUrgical Access and Pattern of Recurrence of Endometrial Cancer: The SUPeR Study, a Multicenter Retrospective Observational Study.
Puppo A, Migliaretti G, Landoni F, Uccella S, Camanni M, Ceccaroni M, Delpiano EM, Mantovani G, Roviglione G, Bianchi T, Grassi T, Maggi V, Garzon S, Galli L, Calandra V, Olearo E. Puppo A, et al. Among authors: migliaretti g. J Minim Invasive Gynecol. 2024 Apr;31(4):321-329. doi: 10.1016/j.jmig.2024.01.016. Epub 2024 Feb 1. J Minim Invasive Gynecol. 2024. PMID: 38301845
A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI.
Porpiglia F, Checcucci E, DE Cillis S, Piramide F, Amparore D, Piana A, Volpi G, Granato S, Zamengo D, Stura I, Alladio E, Migliaretti G, DE Luca S, Bollito E, Gned D, DI Dio M, Autorino R, Manfredi M, Fiori C. Porpiglia F, et al. Among authors: migliaretti g. Minerva Urol Nephrol. 2023 Feb;75(1):31-41. doi: 10.23736/S2724-6051.22.05189-8. Epub 2023 Jan 10. Minerva Urol Nephrol. 2023. PMID: 36626117 Free article. Clinical Trial.
105 results